Age-related macular degeneration (AMD) is a chronic deterioration and dysfunction of the outer retinal tissue and Bruch’s membrane (BrM). It is the leading cause of vision loss in people older than 60 years and is estimated to affect 288 million people ...
Luke G Qin, Venkatkrish M Kasetty, Diego Espinosa-Heidmann
NEW
Retinal pharmacotherapy encompasses various drug delivery routes that offer potential avenues for effective treatment (Figure 1). Among these, intravitreal injections have emerged as the predominant method employed in clinical practice.1Â They have established themselves as the primary approach for administering anti-vascular ...
Alessandro Arrigo, Emanuela Aragona, Francesco Bandello
NEW
Article highlights
Artificial intelligence (AI) represents a powerful way of analysing a large amount of data, extracting those features characterizing a given disease or condition.
AI-based models have been largely tested in the main retinopathies, including age-related macular degeneration, diabetic ...
Login
Sign Up FREE
Log into your Touch Account
Earn and track your CME credits on the go, save articles for later, and follow the latest congress coverage.
Register now for FREE Access
Register for free to hear about the latest expert-led education, peer-reviewed articles, conference highlights, and innovative CME activities.